(1-Methylpiperidin-2-yl)methanamine dihydrochloride is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its structure makes it a valuable building block in the development of drugs targeting the central nervous system, particularly those involved in the modulation of neurotransmitter activity. This compound is often employed in the preparation of potential therapeutic agents for neurological disorders, such as Parkinson's disease, Alzheimer's disease, and other conditions related to dopamine and serotonin pathways. Additionally, it is explored in research for its potential use in creating novel analgesics and antipsychotic medications, owing to its ability to interact with specific receptors in the brain. Its dihydrochloride form enhances solubility, making it more suitable for formulation and experimental studies.